Clinical Trial

Barts-MINOCA Registry

Recruiting
View on ClinicalTrials.gov →
Summary
The last 15 years the introduction of primary angioplasty has radically improved outcomes for acute myocardial infarction (AMI). However, the system wide availability of prompt investigation has revealed an important group of patients where progress has stalled, the diagnosis is unclear and therapeutic approaches are uncertain. Myocardial infarction with non-obstructive coronary arteries (MINOCA) is found in 1 - 13% of all patients with a clinical diagnosis of AMI. These patients present a therapeutic predicament since coronary revascularization is not appropriate. Guidelines do not exist for their management - yet the condition is not benign - the 12-month prognosis, although better than obstructive coronary artery disease patients is still guarded with recent data suggesting many questions remain unanswered.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2020-06-17; most recent amendment 2025-11-17.
Status change: Not Yet Recruiting → Recruiting 2022-02-14
Trial Details
NCT Number NCT04440761
Lead Sponsor Queen Mary University of London
Conditions Myocardial Infarction, Gender, Coronary Microvascular Disease
Enrollment 3,000 participants
Start Date 2020-07-01
Primary Completion 2026-09-16 (estimated)
Study Completion 2026-09-16 (estimated)
Updated on ClinicalTrials.gov 2025-11-18